Search for a command to run...
Regeneron Pharmaceuticals, Inc.
Biotechnology
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Jul 7, 2026 |  Rohit KhannaD | Stock | Buy |
| $15,001 - $50,000 |
| $676.23 |
| $772.11 |
| +14.2% |
| +11.4% |
May 15, 2026 |  Gilbert CisnerosD | Stock | Sell | $1,001 - $15,000 | $697.21 | $612.14 | -12.2% | -12.6% |
May 1, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $700.37 | $614.78 | -12.2% | -17.2% |
Apr 13, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $745.35 | $718.81 | -3.6% | -11.8% |
Feb 12, 2026 |  Julia LetlowR | Stock | Buy | $1,001 - $15,000 | $781.54 | $744.66 | -4.7% | -1.9% |
Jan 29, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $747.42 | $780.50 | +4.4% | +5.6% |
Jan 23, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $751.52 | $778.51 | +3.6% | +3.6% |
Nov 18, 2025 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $722.48 | $746.70 | +3.4% | +0.9% |
Nov 3, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $640.68 | $722.80 | +12.8% | +12.7% |
Sep 29, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $559.37 | $651.31 | +16.4% | +12.9% |
Aug 26, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $586.21 | $554.15 | -5.5% | -7.7% |
Aug 4, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $568.42 | $561.58 | -1.2% | -3.2% |
Jul 25, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $560.03 | $587.16 | +4.8% | +3.6% |
Jul 1, 2025 | Rohit KhannaD | Stock | Buy | $15,001 - $50,000 | $531.99 | $542.49 | +2.0% | -0.4% |
May 19, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $593.30 | $511.54 | -13.8% | -14.2% |
May 15, 2025 |  Rob BresnahanR | Stock | Buy | $1,001 - $15,000 | $581.81 | $527.14 | -9.4% | -10.5% |
Apr 15, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $554.88 | $581.81 | +4.9% | -5.0% |
Apr 10, 2025 |  Byron DonaldsR | Stock | Sell | $1,001 - $15,000 | $543.42 | $524.91 | -3.4% | -11.0% |
Apr 10, 2025 | Byron DonaldsR | Stock | Sell | $1,001 - $15,000 | $543.42 | $524.91 | -3.4% | -11.0% |
Apr 9, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $573.59 | $524.91 | -8.5% | -11.4% |
Apr 8, 2025 | Rob BresnahanR | Stock | Sell | $1,001 - $15,000 | $553.78 | $544.69 | -1.6% | -15.5% |
Apr 7, 2025 |  Jefferson ShreveR | Stock | Sell | $15,001 - $50,000 | $569.67 | $557.88 | -2.1% | -13.3% |
Apr 1, 2025 |  Julie JohnsonD | Stock | Sell | $1,001 - $15,000 | $613.65 | $586.79 | -4.4% | -3.9% |
Mar 13, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $676.91 | $551.17 | -18.6% | -15.7% |
Feb 25, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $719.54 | $632.37 | -12.1% | -7.8% |
Feb 25, 2025 | Rob BresnahanR | Stock | Sell | $1,001 - $15,000 | $719.54 | $632.37 | -12.1% | -7.8% |
Feb 19, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $681.88 | $655.69 | -3.8% | +3.9% |
Feb 12, 2025 | Julie JohnsonD | Stock | Sell | $1,001 - $15,000 | $660.20 | $664.04 | +0.6% | +7.3% |
Jan 24, 2025 |  Josh GottheimerD | Stock | Sell | $1,001 - $15,000 | $672.06 | $697.36 | +3.8% | +5.1% |
Jan 17, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $677.82 | $669.88 | -1.2% | -3.2% |
Jan 15, 2025 | Julie JohnsonD | Stock | Buy | $1,001 - $15,000 | $699.55 | $669.88 | -4.2% | -7.1% |
Dec 18, 2024 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $710.68 | $677.82 | -4.6% | -6.9% |
Dec 16, 2024 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $720.87 | $699.55 | -3.0% | -1.0% |
Disappointing Trial Results Hurt Regeneron Pharmaceuticals (REGN) in Q2
Piper Sandler Maintains Overweight on Regeneron Pharmaceuticals, Lowers Price Target to $854
Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut?
Morgan Stanley Maintains Equal-Weight on Regeneron Pharmaceuticals, Lowers Price Target to $730
Collect 9.0% On VRTX Stock Now, And Still Keep 15% Of Upside